Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 18/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 17/20 | 0.52 |
| ▸ | SORT1 | Q99523 | 15/20 | 0.52 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655911 | 0.94 | GLP1R (0.48) | NTSR1NTSR2SORT1 | |
| SCHEMBL30512644 | 0.89 | NTSR1 (0.56) | NTSR1NTSR2SORT1 | |
| SCHEMBL31179920 | 0.85 | NTSR1 (0.51) | NTSR1NTSR2SORT1 | |
| SCHEMBL29362259 | 0.85 | NPY2R (0.47) | NTSR1NTSR2SORT1 | |
| SCHEMBL30280345 | 0.84 | NPY2R (0.53) | NTSR1NTSR2SORT1 | |
| SCHEMBL29805251 | 0.84 | NPY2R (0.47) | NTSR1NTSR2SORT1 | |
| SCHEMBL30512495 | 0.84 | NTSR1 (0.55) | NTSR1NTSR2SORT1 | |
| SCHEMBL31295889 | 0.83 | NTSR1 (0.61) | NTSR1NTSR2SORT1 | |
| SCHEMBL29470909 | 0.83 | CAPN1 (0.44) | CAPN1 | |
| SCHEMBL29959462 | 0.82 | NTSR2 (0.51) | NTSR1NTSR2SORT1CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | claimed |
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | CYP24A1, CYP27B1, CYP2R1 | NTSR1 1564/4885NTSR2 1678/4885SORT1 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.